Articles

T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers

Immune and Gene Therapy Laboratory, Department of Oncology & Pathology, Cancer Centre Karolinska, Karolinska Institutet, Stockholm, Sweden;Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
Immune and Gene Therapy Laboratory, Department of Oncology & Pathology, Cancer Centre Karolinska, Karolinska Institutet, Stockholm, Sweden
Immune and Gene Therapy Laboratory, Department of Oncology & Pathology, Cancer Centre Karolinska, Karolinska Institutet, Stockholm, Sweden
Immune and Gene Therapy Laboratory, Department of Oncology & Pathology, Cancer Centre Karolinska, Karolinska Institutet, Stockholm, Sweden
Immune and Gene Therapy Laboratory, Department of Oncology & Pathology, Cancer Centre Karolinska, Karolinska Institutet, Stockholm, Sweden
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Immune and Gene Therapy Laboratory, Department of Oncology & Pathology, Cancer Centre Karolinska, Karolinska Institutet, Stockholm, Sweden;Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
Immune and Gene Therapy Laboratory, Department of Oncology & Pathology, Cancer Centre Karolinska, Karolinska Institutet, Stockholm, Sweden;Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
Immune and Gene Therapy Laboratory, Department of Oncology & Pathology, Cancer Centre Karolinska, Karolinska Institutet, Stockholm, Sweden
Vol. 102 No. 3 (2017): March, 2017 https://doi.org/10.3324/haematol.2016.151100